- Email: [email protected]
Liste des participants et auditeurs
GARNIER
INRA.
GONNARD, P.
H6pital Henri Mondor, Service de Biologie, 94 - Cr6teil.
GROS, F."
Institut de Biologie Mol6culaire, Universit6 de Paris VII, Paris (Se).
HAIDAS, S.
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
HAKIM, J.
H6pital Beaujon, D6partement d'H6matologie, 92- Clichy.
HATZFELDj A.
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
HERS, H. G.*
Universit6 Catholique de Louvain, Laboratoire de Chimie Physiologique, Louvain, Belgique.
HOLL£N, S. *
Institute of Haematology, National Blood Center, Budapest, Hongrie.
HOPKINSON, D. A.*
Medical Research Council Human Biochemical Genetics Unit, University College London, London NW1, Grande-Bretagne.
HUPPERT, J.
Institut du Cancer, 94- ¥illejuif.
HUYNH VAN TAN.
Institut de Pathologic Mol6culaire, C.H.U. Cochin, Paris (14°).
JANIN, J.
Institut Pasteur, Paris (150.
JUNIEN, C.
Institut de Pathologic Mol6culaire, C.H.U. Cochin, Paris (140.
KAHN, A.
H6pital Beaujon, Laboratoire d'Enzymologie, 92 - Clichy.
KAMIYAMA, M.
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (14e).
KAPLAN, J. C.*
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
KAREEM, H. A.
Institut de Chimie des Substances Naturelles, 91-Gif-surYvette.
KRUH, J.*
Institut de Pathologic Mol6culaire, C.H.U. Cochin, Paris (14°).
LABIE, D.*
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
LAMBOTTE, C.
Universit6 de Liege, 400.0 - - Libge, Belgique.
LAUDAT,M. H.
Unit6 de Recherches sur le M6tabolisme des Lipides, H6pital Cochin, Paris (14~).
LAUDAT,Ph.*
Unit6 de Recherches sur le M6tabolisme des Lipides, H6pital Cochin, Paris (140.
LEDERER, E.
Institut de Chimie des Substances Naturelles, 91- Gif-surYvette.
LEROUX, J. P.
H6pital des Enfants Malades, Laboratoire de Biochimie, Paris (15°).
LEVY, F.
Institut de Pathologie MoMculaire, C.H.U. Cochin, Paris (14e).
LORKIN, P. A.
Medical Research Council Abnormal Haemoglobin Unit, Department of Biochemistry, Cambridge, Grande-Bretagne.
MALEKNIA,N.
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
MARKS, P.*
Columbia University, New-York, U.S.A.
MEIENHOFER, M. C.
Institut de Pathologie Mol~culaire, C.H.U. Cochin, Paris (140.
MONOD, J.*
Institut Pasteur, Paris (150.
MOTULSKY, A.*
School of Medicine, Washington, U.S.A.
University
of Washington,
Seattle,
MOULTS, Y.
lnstitut du Cancer, 94 - Villejuif.
NADLER, H. L."
Children's Memorial Hospital, Northwestern University Medical School, Chicago, Illinois, U.S.A.
NAJMAN, A.
HOpital Saint-Antoine, Service d'Hdmatologie, Paris (12e).
NECHAUD, B. de
Institut du Cancer, 94- Villejuif.
NORDMANN, "Y.*
HOpital de Colombes, 92-Colombes.
PAGOULATOS, G.
Institut de Biologie Paris (5°).
PERUTZ, M. F.*
Medical Research Council Laboratory of Molecular Biology, Cambridge, Grande-Bretagne.
RAMOT, B.*
Government Hospital Tel-Hashomer, Department of Hematology, Tel-Hashomer, Israel.
RANNEY, H. *
E. J. Meyer Memorial Hospital, Department of Medicine, Buffalo, New York, U.S.A.
ROSA, J.*
HOpital Henri Mondor, Service de Biologie, 94-CrOteil.
ROYER, P.*
HSpital des Enfants Malades, Clinique de GOnOtique MOdicale, Paris (15°).
SCHAPIRA, F.*
Institut de Pathologie MolOculaire, C.H.U. Cochin, Paris (140.
SCHAPIRA, G.*
Institut de Pathologie MolOculaire, C.H.U. Cochin, Paris (140.
SCHAPIRO, D.
The Weizmann Institute of Science, Rehovoth, Israel.
SEEGMILLER, J. E.*
University of California, San Diego, Department of Medicine, La Jolla, California, U.S.A.
SINISCALCO, M.*
Universit6 de Naples, DOpartement de GOnOtique, Naples, Italie.
TRAVERSE, P. M. de
Institut de Biologie, HOpital Cochin, Paris (140.
VAN HOOF, F.*
Universit6 Catholique de Louvain, Laboratoire de Chimie Physiologique, Louvain, Belgique.
"VERDIER, C. H. de*
University Hospital, Uppsala, Suede.
•ESELL, E. S."
The Pennsylvania State University, Hershey, Penn. U.S.A.
WAJCMAN, H.
Institut de Pathologie MolOculaire, C.H.U. Cochin, Paris (140.
MolOculaire,
Department
Universit6
of
Clinical
Paris
VII,
Chemistry
WEATHERALL, D. J.* Nuffield Unit of Medical Genetics, Sub-Department of Haematology, Liverpool, Grande-Bretagne. WEIMANN, G.
Biochemische Forschungszentrum, Tutzing, ROpublique FddOrale Allemande.
WEINHOUSE, S.*
Temple University, Fels Research Institute, Philadelphia, Pennsylvania, U.S.A.
WHITE, J. M.*
Hammersmith Hospital, Department of Pathology, London W.12, Grande-Bretagne.
WILLIAMSON R.*
The Beatson Institute for Cancer Research, Glasgow C.3, Ecosse.
YOSHIDA, A.
University of Washington, Division of Medical Genetics, Seattle, Washington, U.S.A.
ZUCKERKANDL,E.*
C. N. R.S., DOpartement 34 - Montpellier.
de
Biochimie
MacromolOculaire,
INRA.
GONNARD, P.
H6pital Henri Mondor, Service de Biologie, 94 - Cr6teil.
GROS, F."
Institut de Biologie Mol6culaire, Universit6 de Paris VII, Paris (Se).
HAIDAS, S.
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
HAKIM, J.
H6pital Beaujon, D6partement d'H6matologie, 92- Clichy.
HATZFELDj A.
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
HERS, H. G.*
Universit6 Catholique de Louvain, Laboratoire de Chimie Physiologique, Louvain, Belgique.
HOLL£N, S. *
Institute of Haematology, National Blood Center, Budapest, Hongrie.
HOPKINSON, D. A.*
Medical Research Council Human Biochemical Genetics Unit, University College London, London NW1, Grande-Bretagne.
HUPPERT, J.
Institut du Cancer, 94- ¥illejuif.
HUYNH VAN TAN.
Institut de Pathologic Mol6culaire, C.H.U. Cochin, Paris (14°).
JANIN, J.
Institut Pasteur, Paris (150.
JUNIEN, C.
Institut de Pathologic Mol6culaire, C.H.U. Cochin, Paris (140.
KAHN, A.
H6pital Beaujon, Laboratoire d'Enzymologie, 92 - Clichy.
KAMIYAMA, M.
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (14e).
KAPLAN, J. C.*
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
KAREEM, H. A.
Institut de Chimie des Substances Naturelles, 91-Gif-surYvette.
KRUH, J.*
Institut de Pathologic Mol6culaire, C.H.U. Cochin, Paris (14°).
LABIE, D.*
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
LAMBOTTE, C.
Universit6 de Liege, 400.0 - - Libge, Belgique.
LAUDAT,M. H.
Unit6 de Recherches sur le M6tabolisme des Lipides, H6pital Cochin, Paris (14~).
LAUDAT,Ph.*
Unit6 de Recherches sur le M6tabolisme des Lipides, H6pital Cochin, Paris (140.
LEDERER, E.
Institut de Chimie des Substances Naturelles, 91- Gif-surYvette.
LEROUX, J. P.
H6pital des Enfants Malades, Laboratoire de Biochimie, Paris (15°).
LEVY, F.
Institut de Pathologie MoMculaire, C.H.U. Cochin, Paris (14e).
LORKIN, P. A.
Medical Research Council Abnormal Haemoglobin Unit, Department of Biochemistry, Cambridge, Grande-Bretagne.
MALEKNIA,N.
Institut de Pathologie Mol6culaire, C.H.U. Cochin, Paris (140.
MARKS, P.*
Columbia University, New-York, U.S.A.
MEIENHOFER, M. C.
Institut de Pathologie Mol~culaire, C.H.U. Cochin, Paris (140.
MONOD, J.*
Institut Pasteur, Paris (150.
MOTULSKY, A.*
School of Medicine, Washington, U.S.A.
University
of Washington,
Seattle,
MOULTS, Y.
lnstitut du Cancer, 94 - Villejuif.
NADLER, H. L."
Children's Memorial Hospital, Northwestern University Medical School, Chicago, Illinois, U.S.A.
NAJMAN, A.
HOpital Saint-Antoine, Service d'Hdmatologie, Paris (12e).
NECHAUD, B. de
Institut du Cancer, 94- Villejuif.
NORDMANN, "Y.*
HOpital de Colombes, 92-Colombes.
PAGOULATOS, G.
Institut de Biologie Paris (5°).
PERUTZ, M. F.*
Medical Research Council Laboratory of Molecular Biology, Cambridge, Grande-Bretagne.
RAMOT, B.*
Government Hospital Tel-Hashomer, Department of Hematology, Tel-Hashomer, Israel.
RANNEY, H. *
E. J. Meyer Memorial Hospital, Department of Medicine, Buffalo, New York, U.S.A.
ROSA, J.*
HOpital Henri Mondor, Service de Biologie, 94-CrOteil.
ROYER, P.*
HSpital des Enfants Malades, Clinique de GOnOtique MOdicale, Paris (15°).
SCHAPIRA, F.*
Institut de Pathologie MolOculaire, C.H.U. Cochin, Paris (140.
SCHAPIRA, G.*
Institut de Pathologie MolOculaire, C.H.U. Cochin, Paris (140.
SCHAPIRO, D.
The Weizmann Institute of Science, Rehovoth, Israel.
SEEGMILLER, J. E.*
University of California, San Diego, Department of Medicine, La Jolla, California, U.S.A.
SINISCALCO, M.*
Universit6 de Naples, DOpartement de GOnOtique, Naples, Italie.
TRAVERSE, P. M. de
Institut de Biologie, HOpital Cochin, Paris (140.
VAN HOOF, F.*
Universit6 Catholique de Louvain, Laboratoire de Chimie Physiologique, Louvain, Belgique.
"VERDIER, C. H. de*
University Hospital, Uppsala, Suede.
•ESELL, E. S."
The Pennsylvania State University, Hershey, Penn. U.S.A.
WAJCMAN, H.
Institut de Pathologie MolOculaire, C.H.U. Cochin, Paris (140.
MolOculaire,
Department
Universit6
of
Clinical
Paris
VII,
Chemistry
WEATHERALL, D. J.* Nuffield Unit of Medical Genetics, Sub-Department of Haematology, Liverpool, Grande-Bretagne. WEIMANN, G.
Biochemische Forschungszentrum, Tutzing, ROpublique FddOrale Allemande.
WEINHOUSE, S.*
Temple University, Fels Research Institute, Philadelphia, Pennsylvania, U.S.A.
WHITE, J. M.*
Hammersmith Hospital, Department of Pathology, London W.12, Grande-Bretagne.
WILLIAMSON R.*
The Beatson Institute for Cancer Research, Glasgow C.3, Ecosse.
YOSHIDA, A.
University of Washington, Division of Medical Genetics, Seattle, Washington, U.S.A.
ZUCKERKANDL,E.*
C. N. R.S., DOpartement 34 - Montpellier.
de
Biochimie
MacromolOculaire,